Get the Stockscreener App
29.50
3.78%
-1.16
Pre-market:
29.40
-0.10
-0.34%
ARK Genomic Revolution ETF stock is traded at $29.50, with a volume of 4.03M.
It is down -3.78% in the last 24 hours and down -1.80% over the past month.
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
See More
Previous Close:
$30.66
Open:
$29.8
24h Volume:
4.03M
Relative Volume:
1.40
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.12%
1M Performance:
-1.80%
6M Performance:
+30.13%
1Y Performance:
+21.55%
1-Day Range:
$29.48
$30.52
1-Week Range:
$29.48
$31.31
52-Week Range:
$17.50
$34.06
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Name
ARK Genomic Revolution ETF
Sector
Industry
Phone
855-406-1506
Address
-
Compare ARKG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
29.50 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
331.74 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
675.24 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
678.81 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
251.12 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
619.25 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF Stock (ARKG) Latest News
Why analysts raise outlook for ARK Genomic Revolution ETF stock2025 Institutional Moves & Safe Swing Trade Setup Alerts - newser.com
CRSP, BEAM, ROKU, SOFI: Cathie Wood Pours $17 Million into Biotech Stocks, Trims Tech Favorites - TipRanks
How reliable is ARK Genomic Revolution ETF stock dividend growthTrade Signal Summary & Consistent Return Strategy Ideas - newser.com
Is ARK Genomic Revolution ETF stock nearing a technical breakoutJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - newser.com
Cathie Wood Steps Up Bet on Bullish Stock (BLSH), Trims Stake in Palantir (PLTR) amid Strong Q3 Earnings - TipRanks
Can ARK Genomic Revolution ETF stock surprise with quarterly resultsTrade Volume Report & High Conviction Buy Zone Picks - newser.com
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? - Benzinga
P 500 performance this yearEarnings Growth Report & Weekly Breakout Stock Alerts - newser.com
What dividend safety rating applies to ARK Genomic Revolution ETF stockJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - newser.com
How ARK Genomic Revolution ETF stock performs during market turbulenceWeekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com
Cathie Wood Bets Big on Alibaba, Baidu, and Arcturus, Trims Stake in AMD, SoFi, and Shopify - MSN
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Cathie Wood's Ark Invest weekly recap: sheds shares in Palantir Technologies, Shopify, Roblox - MSN
Cathie Wood Boosts Biotech and DraftKings Stakes, Trims Shopify - TipRanks
Cathie Wood’s ARK Invest Sells AMD and Shopify to Buy Block and Robinhood Stock - parameter.io
Largest borrow rate increases among liquid names - TipRanks
Cathie Wood's ARK Invest Sells AMD and Shopify While Adding Block and Robinhood Shares - CoinCentral
Ark Invest CEO Cathie Wood warns of potential AI market correction: ‘A reality check is coming' (ARKK:BATS) - Seeking Alpha
Cathie Wood Trims Exposure to AMD and Other U.S. Tech Favorites, Doubles Down on Baidu and Biotech Plays - TipRanks
Cathie Wood’s ARK Invest Sells AMD and Shopify, Adds Netflix and Robinhood - parameter.io
Cathie Wood's weekly recap: sells AMD, Shopify, builds exposure in Chinese AI, biotech & Netflix - Seeking Alpha
ARK Genomic Revolution ETF Stock (ARKG) Financials Data
There is no financial data for ARK Genomic Revolution ETF (ARKG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.30%
Cap:
|
Volume (24h):